This page tells you the terms of use on which you may make use of the website www.talkaboutlaminitis.co.uk, whether as a visitor or a registered user. Please read these terms of use carefully before you start to use the Site. By using the Site, you indicate that you accept these terms of use and that you agree to abide by them. If you do not agree to these terms of use, please refrain from using the Site.
www.talkaboutlaminitis.co.uk is a site operated by Boehringer Ingelheim Limited ("We"). We are a private limited company registered in England and Wales under company number 00711858 and have our registered office (and main trading address) at Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS. Our VAT number is 200356126.
We are regulated by the MHRA, ABPI and PAGB for human medicines and NOAH (UK), VMD (UK), APHA (Ireland), HPRA (Ireland) and the EMEA (Europe) for our veterinary medicines.
Access to the Site is permitted on a temporary basis, and we reserve the right to withdraw or amend the service we provide on the Site without notice (see below). We will not be liable if for any reason the Site is unavailable at any time or for any period.
From time to time, we may restrict access to some parts or all of the Site, to users who have registered with us.
You are responsible for making all arrangements necessary for you to have access to the Site. You are also responsible for ensuring that all persons who access the Site through your internet connection are aware of these terms, and that they comply with them.
We are the owner or the licensee of all intellectual property rights in the Site, and in our material published on it. Some of the content of the Site will be subject to the intellectual property rights of third parties. All works are protected by copyright laws and treaties around the world. All such rights are reserved.
You may print off one copy, and may download extracts, of any page(s) from the Site for your personal reference and you may draw the attention of others within your organisation to material posted on the Site.
Permission to use documents (such as white papers, press releases, datasheets and FAQs) from the Site is granted, provided that (1) this notice appears in all copies and that, in particular, both the copyright notice and this permission notice appear, and (2) use of such documents from this Site is for informational, media and non-commercial or personal use only and will not be copied or posted on any network computer or broadcast in commercial media.
You must not modify the paper or digital copies of any materials you have printed off or downloaded in any way, and you must not use any illustrations, photographs, video or audio sequences or any graphics separately from any accompanying text.
Our status (and that of any identified contributors) as the authors of material on the Site must always be acknowledged.
You must not use any part of the materials on the Site for commercial purposes without obtaining a licence to do so from us or our licensors or the relevant owners.
If you print off, copy or download any part of the Site in breach of these terms of use, your right to use the Site will cease immediately and you must, at our option, return or destroy any copies of the materials you have made.
Commentary, articles, press releases and other materials posted on the Site are not intended to amount to advice on which reliance should be placed. We therefore disclaim all liability and responsibility arising from any reliance placed on such materials by any visitor to the Site, or by anyone who may be informed of any of its contents.
We may update the Site, and may change the content at any time. If the need arises, we may suspend access to the Site, or close it indefinitely. Any of the material on the Site may be out of date at any given time, and we are under no obligation to update such material.
The material displayed on the Site is provided without any guarantees, conditions or warranties as to its accuracy. To the extent permitted by law, we, other members of our group of companies and third parties connected to us hereby expressly exclude:
This does not affect our liability for death or personal injury arising from our negligence, nor our liability for fraud or fraudulent misrepresentation, nor any other liability which cannot be excluded or limited under applicable law.
Information on pharmaceutical products are not intended to be used as an alternative to consulting with a health care professional or other qualified professional. If you require advice on a specific health problem please contact health care professionals.
The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Boehringer Ingelheim Limited and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.
It is impossible to regulate downloads from the Site and possible viruses which they may contain. Boehringer Ingelheim Limited does not accept liability for any virus infection or resulting problems which may arise from the use of the Site.
We process information about you in accordance with our privacy policy. By using the Site, you consent to such processing and you warrant that all data provided by you is accurate.
You must not misuse the Site by knowingly introducing viruses, trojans, worms, logic bombs or other material which is malicious or technologically harmful. You must not attempt to gain unauthorised access to the Site, the server on which the Site is stored or any server, computer or database connected to the Site. You must not attack the Site via a denial-of-service attack or a distributed denial-of service attack.
By breaching this provision, you would commit a criminal offence under the Computer Misuse Act 1990. We will report any such breach to the relevant law enforcement authorities and we will co-operate with those authorities by disclosing your identity to them. In the event of such a breach, your right to use the Site will cease immediately.
We will not be liable for any loss or damage caused by a distributed denial-of-service attack, viruses or other technologically harmful material that may infect your computer equipment, computer programs, data or other proprietary material due to your use of the Site or to your downloading of any material posted on it, or on any website linked to it.
Where the Site contains links to other sites and resources provided by third parties, these links are provided for your information only. We have no control over the contents of those sites or resources, and accept no responsibility for them or for any loss or damage that may arise from your use of them.
The English courts will have exclusive jurisdiction over any claim arising from, or related to, a visit to our site (although we retain the right to bring proceedings against you for breach of these conditions in your country of residence or any other relevant country).
These terms of use and any dispute or claim arising out of or in connection with them or their subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with the law of England and Wales.
Copyright © 2018 Boehringer Ingelheim Limited. All rights reserved.
The trade names of Boehringer Ingelheim products referenced herein, whether or not appearing in bold characters or with the trademark symbol ®, are trademarks of entities of the Boehringer Ingelheim Group. The names of actual companies and products mentioned herein may be the trademarks of their respective owners. The use of these trademarks, except as permitted herein, is expressly prohibited and may be in violation of law.
We may revise these terms of use at any time by amending this page. You are expected to check this page from time to time to take notice of any changes we made, as they are binding on you. Some of the provisions contained in these terms of use may also be superseded by provisions or notices published elsewhere on our websites.
If you have any concerns about material which appears on the Site, please contact communications@bra.boehringer-ingelheim.com
Queries and other feedback addressed to Boehringer Ingelheim Limited through this website should not contain questions on personal health matters or on specific prescription-only products but should be addressed to a health care professional.
The Talk About Laminitis initiative continues to do sterling work in awareness-raising but also crucially in increasing the information we have about the disease and related conditions.
PPID (Cushing’s disease) is a significant risk factor for developing the devastating disease of laminitis, but thanks to this initiative, more cases can be identified early.
We encourage all horse owners, who are concerned about PPID in their horses, to take up this fantastic complimentary offer.
